Gene symbol   |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
2900073G 15Rik | |
NM_026064 |
RIKEN cDNA 2900073G15 gene (2900073G15Rik), mRNA [NM_026064] |
KLA | 1.50 |
1.46 |
1.64 |
1.51 |
1.69 |
1.72 |
1.15 |
| ATP | 1.05 |
1.10 |
1.24 |
1.39 |
1.23 |
1.13 |
1.03 |
| KLA/ATP | 1.50 |
1.60 |
1.64 |
1.71 |
1.36 |
1.21 |
1.11 |
|
4930468A 15Rik | |
AK015525 |
adult male testis cDNA, RIKEN full-length enriched library, clone:4930468A15 product:hypothetical protein, full insert sequence [AK015525] |
KLA | .97 |
1.00 |
1.03 |
.98 |
1.02 |
1.01 |
1.02 |
| ATP | 1.03 |
.97 |
1.05 |
1.02 |
.99 |
.98 |
.98 |
| KLA/ATP | 1.01 |
1.00 |
.97 |
1.01 |
.95 |
.98 |
.96 |
|
Actb | |
BC016624 |
cDNA clone IMAGE:4501052 [BC016624] |
KLA | 1.20 |
1.20 |
1.19 |
1.73 |
1.83 |
2.52 |
1.70 |
| ATP | 1.04 |
1.01 |
1.03 |
.92 |
1.07 |
.66 |
.91 |
| KLA/ATP | 1.34 |
1.40 |
1.69 |
1.28 |
1.27 |
1.19 |
1.06 |
|
Actb | |
NM_007393 |
actin, beta, cytoplasmic (Actb), mRNA [NM_007393] |
KLA | 1.58 |
1.64 |
1.59 |
2.02 |
2.03 |
3.04 |
1.75 |
| ATP | 1.00 |
.95 |
1.26 |
1.18 |
1.33 |
.86 |
.91 |
| KLA/ATP | 1.52 |
1.75 |
2.42 |
1.92 |
2.17 |
1.54 |
1.28 |
|
Actg1 | |
NM_009609 |
actin, gamma, cytoplasmic 1 (Actg1), mRNA [NM_009609] |
KLA | 1.02 |
1.03 |
1.34 |
1.07 |
1.49 |
1.58 |
.71 |
| ATP | 1.07 |
1.24 |
.76 |
.76 |
.63 |
.46 |
.78 |
| KLA/ATP | 1.20 |
1.30 |
.75 |
.82 |
.60 |
.53 |
.55 |
|
Actn1 | |
NM_134156 |
actinin, alpha 1 (Actn1), mRNA [NM_134156] |
KLA | 1.33 |
1.42 |
1.46 |
1.16 |
1.18 |
.69 |
.54 |
| ATP | 1.06 |
1.13 |
.67 |
1.15 |
.95 |
.99 |
1.46 |
| KLA/ATP | 1.66 |
1.64 |
.81 |
1.55 |
.82 |
.78 |
.76 |
|
Actn2 | |
NM_033268 |
actinin alpha 2 (Actn2), mRNA [NM_033268] |
KLA | 1.03 |
.94 |
1.02 |
1.05 |
1.02 |
1.06 |
1.11 |
| ATP | 1.04 |
.98 |
1.07 |
.99 |
1.10 |
1.03 |
1.02 |
| KLA/ATP | 1.06 |
1.03 |
.99 |
1.08 |
1.01 |
1.05 |
.98 |
|
Actn3 | |
NM_013456 |
actinin alpha 3 (Actn3), mRNA [NM_013456] |
KLA | .97 |
.98 |
.98 |
.94 |
1.03 |
.96 |
1.07 |
| ATP | .95 |
.95 |
1.02 |
.98 |
.94 |
.95 |
1.01 |
| KLA/ATP | 1.05 |
1.03 |
.94 |
1.03 |
1.03 |
1.00 |
.95 |
|
Actn4 | |
NM_021895 |
actinin alpha 4 (Actn4), mRNA [NM_021895] |
KLA | .78 |
.77 |
.75 |
.74 |
.58 |
.51 |
.65 |
| ATP | 1.03 |
1.03 |
1.21 |
1.14 |
1.50 |
1.30 |
1.09 |
| KLA/ATP | .78 |
.85 |
.96 |
.84 |
1.09 |
1.12 |
.97 |
|
AK049504
| |
AK049504 |
7 days embryo whole body cDNA, RIKEN full-length enriched library, clone:C430017P18 product:hypothetical protein, full insert sequence. [AK049504] |
KLA | 1.03 |
.99 |
.99 |
1.03 |
1.03 |
.98 |
.94 |
| ATP | .96 |
1.04 |
1.03 |
1.02 |
1.01 |
1.02 |
.98 |
| KLA/ATP | 1.03 |
.99 |
1.06 |
.98 |
.97 |
.94 |
1.06 |
|
AK078768
| |
AK078768 |
15 days embryo male testis cDNA, RIKEN full-length enriched library, clone:8030463G20 product:unclassifiable, full insert sequence. [AK078768] |
KLA | 1.00 |
1.04 |
1.01 |
1.00 |
1.01 |
.99 |
.92 |
| ATP | .94 |
1.03 |
1.07 |
.96 |
.97 |
.95 |
.99 |
| KLA/ATP | .95 |
.99 |
1.02 |
1.04 |
.99 |
.99 |
1.01 |
|
Akt1 | |
NM_009652 |
thymoma viral proto-oncogene 1 (Akt1), mRNA [NM_009652] |
KLA | .80 |
.80 |
.75 |
.75 |
.71 |
.70 |
.82 |
| ATP | 1.00 |
1.02 |
.76 |
.85 |
.76 |
.68 |
.84 |
| KLA/ATP | .82 |
.80 |
.64 |
.68 |
.67 |
.61 |
.72 |
|
Akt2 | |
NM_007434 |
thymoma viral proto-oncogene 2 (Akt2), transcript variant 2, mRNA [NM_007434] |
KLA | 1.45 |
1.49 |
1.81 |
1.61 |
1.83 |
1.17 |
.92 |
| ATP | 1.12 |
1.12 |
1.00 |
1.28 |
1.20 |
.94 |
1.06 |
| KLA/ATP | 1.48 |
1.70 |
1.69 |
1.58 |
1.57 |
1.32 |
1.27 |
|
Akt3 | |
NM_011785 |
thymoma viral proto-oncogene 3 (Akt3), mRNA [NM_011785] |
KLA | 3.42 |
3.45 |
5.31 |
5.16 |
4.65 |
3.80 |
2.12 |
| ATP | 1.12 |
1.22 |
1.10 |
1.37 |
1.02 |
1.11 |
1.56 |
| KLA/ATP | 3.72 |
4.17 |
4.62 |
4.64 |
2.74 |
2.05 |
3.82 |
|
Amotl1 | |
NM_001081395 |
angiomotin-like 1 (Amotl1), mRNA [NM_001081395] |
KLA | .97 |
.96 |
.89 |
.87 |
.94 |
.94 |
.95 |
| ATP | 1.03 |
1.05 |
1.00 |
.98 |
.97 |
1.06 |
1.13 |
| KLA/ATP | .95 |
.92 |
.90 |
.95 |
.93 |
.94 |
.99 |
|
Ash1l | |
NM_138679 |
ash1 (absent, small, or homeotic)-like (Drosophila) (Ash1l), mRNA [NM_138679] |
KLA | 1.23 |
1.04 |
1.03 |
1.04 |
1.29 |
1.17 |
1.27 |
| ATP | 1.18 |
1.23 |
1.32 |
1.55 |
1.83 |
1.60 |
1.35 |
| KLA/ATP | 1.25 |
1.19 |
1.22 |
1.25 |
1.54 |
1.57 |
1.72 |
|
B230120H 23Rik | |
NM_023057 |
RIKEN cDNA B230120H23 gene (B230120H23Rik), transcript variant 1, mRNA [NM_023057] |
KLA | 1.35 |
1.36 |
1.17 |
.91 |
.69 |
.43 |
.56 |
| ATP | 1.01 |
1.12 |
.87 |
1.32 |
1.71 |
1.48 |
.63 |
| KLA/ATP | 1.37 |
1.46 |
.95 |
1.14 |
1.07 |
1.22 |
.78 |
|
B230120H 23Rik | |
NM_178084 |
RIKEN cDNA B230120H23 gene (B230120H23Rik), transcript variant 2, mRNA [NM_178084] |
KLA | 1.08 |
1.07 |
1.06 |
1.00 |
.87 |
.62 |
.68 |
| ATP | 1.11 |
1.24 |
1.41 |
1.31 |
1.49 |
1.04 |
.79 |
| KLA/ATP | 1.13 |
1.24 |
1.17 |
1.07 |
1.04 |
.89 |
.85 |
|
Cask | |
NM_009806 |
calcium/calmodulin-dependent serine protein kinase (MAGUK family) (Cask), mRNA [NM_009806] |
KLA | 1.92 |
2.00 |
2.43 |
2.97 |
2.71 |
1.46 |
1.01 |
| ATP | .96 |
.99 |
.90 |
.88 |
.75 |
1.08 |
.74 |
| KLA/ATP | 1.72 |
1.79 |
1.84 |
1.57 |
1.23 |
1.06 |
.75 |
|
Cdc42 | |
NM_009861 |
cell division cycle 42 homolog (S. cerevisiae) (Cdc42), mRNA [NM_009861] |
KLA | 1.04 |
1.01 |
1.02 |
1.04 |
1.12 |
1.21 |
1.12 |
| ATP | 1.07 |
1.10 |
1.04 |
1.06 |
1.02 |
.95 |
1.14 |
| KLA/ATP | .94 |
1.04 |
1.01 |
.97 |
.95 |
1.02 |
1.25 |
|
Cdk4 | |
NM_009870 |
cyclin-dependent kinase 4 (Cdk4), mRNA [NM_009870] |
KLA | .66 |
.72 |
.65 |
.55 |
.46 |
.50 |
.71 |
| ATP | 1.03 |
1.02 |
.53 |
.65 |
.66 |
.63 |
.75 |
| KLA/ATP | .78 |
.61 |
.31 |
.42 |
.44 |
.62 |
.43 |
|
CF586908
| |
CF586908 |
gb|AGENCOURT_8784932_updated NIH_MGC_140 Mus musculus cDNA clone IMAGE:6436450 5, mRNA sequence [CF586908] |
KLA | 1.01 |
1.01 |
1.01 |
.98 |
1.04 |
1.04 |
1.05 |
| ATP | 1.03 |
.94 |
1.02 |
1.07 |
1.07 |
1.01 |
1.07 |
| KLA/ATP | .99 |
1.00 |
1.04 |
1.11 |
1.14 |
1.04 |
1.00 |
|
Cgn | |
AK018143 |
adult male medulla oblongata cDNA, RIKEN full-length enriched library, clone:6330408J11 product:similar to CINGULIN [Homo sapiens], full insert sequence. [AK018143] |
KLA | 1.01 |
1.00 |
1.04 |
1.01 |
1.11 |
1.08 |
1.02 |
| ATP | .97 |
.96 |
1.02 |
1.02 |
.95 |
.96 |
1.04 |
| KLA/ATP | .93 |
1.07 |
.95 |
.97 |
1.00 |
.96 |
.99 |
|
Cgn | |
XM_001001375 |
gb|PREDICTED: Mus musculus cingulin (Cgn), mRNA [XM_001001375] |
KLA | .99 |
.99 |
1.05 |
.94 |
1.01 |
.97 |
.95 |
| ATP | .96 |
1.05 |
1.02 |
.94 |
.97 |
.97 |
.95 |
| KLA/ATP | .96 |
1.01 |
.99 |
1.01 |
.97 |
.93 |
.99 |
|
Cldn1 | |
NM_016674 |
claudin 1 (Cldn1), mRNA [NM_016674] |
KLA | .97 |
1.02 |
1.02 |
1.05 |
1.05 |
.99 |
1.07 |
| ATP | 1.02 |
.94 |
1.03 |
1.08 |
1.05 |
.98 |
1.02 |
| KLA/ATP | 1.03 |
1.02 |
1.00 |
1.00 |
1.17 |
1.01 |
1.03 |
|
Cldn10 | |
NM_021386 |
claudin 10 (Cldn10), transcript variant 2, mRNA [NM_021386] |
KLA | 1.06 |
1.05 |
1.04 |
1.12 |
1.08 |
1.05 |
1.04 |
| ATP | 1.07 |
.97 |
.98 |
1.06 |
1.00 |
1.01 |
.97 |
| KLA/ATP | 1.01 |
1.06 |
.86 |
.98 |
1.03 |
1.04 |
1.09 |
|
Cldn11 | |
NM_008770 |
claudin 11 (Cldn11), mRNA [NM_008770] |
KLA | 1.05 |
1.10 |
1.04 |
.99 |
.97 |
.99 |
.97 |
| ATP | 1.03 |
1.01 |
1.08 |
3.05 |
1.24 |
1.11 |
1.07 |
| KLA/ATP | 1.02 |
.96 |
1.42 |
2.53 |
1.09 |
1.02 |
1.03 |
|
Cldn13 | |
NM_020504 |
claudin 13 (Cldn13), mRNA [NM_020504] |
KLA | 1.02 |
1.00 |
1.02 |
.97 |
1.01 |
.98 |
.99 |
| ATP | .92 |
.96 |
1.05 |
.96 |
1.02 |
1.04 |
1.04 |
| KLA/ATP | .93 |
.94 |
1.10 |
1.06 |
1.00 |
.93 |
1.03 |
|
Cldn14 | |
NM_019500 |
claudin 14 (Cldn14), mRNA [NM_019500] |
KLA | 1.03 |
1.12 |
1.14 |
1.08 |
1.09 |
1.16 |
1.08 |
| ATP | 1.03 |
.99 |
1.12 |
1.04 |
1.07 |
1.10 |
1.06 |
| KLA/ATP | 1.07 |
1.14 |
1.21 |
1.12 |
1.07 |
1.10 |
1.08 |
|
Cldn15 | |
NM_021719 |
claudin 15 (Cldn15), mRNA [NM_021719] |
KLA | 1.01 |
1.07 |
1.04 |
1.09 |
1.06 |
1.11 |
.98 |
| ATP | 1.17 |
1.26 |
1.27 |
1.08 |
1.24 |
1.11 |
1.05 |
| KLA/ATP | 1.25 |
1.31 |
1.19 |
1.22 |
1.70 |
1.26 |
1.03 |
|
Cldn16 | |
NM_053241 |
claudin 16 (Cldn16), mRNA [NM_053241] |
KLA | 1.08 |
.98 |
1.02 |
1.00 |
1.06 |
1.05 |
1.00 |
| ATP | 1.01 |
1.05 |
1.01 |
1.12 |
1.05 |
.98 |
.99 |
| KLA/ATP | .98 |
.95 |
1.04 |
1.05 |
1.02 |
1.15 |
1.01 |
|
Cldn17 | |
NM_181490 |
claudin 17 (Cldn17), mRNA [NM_181490] |
KLA | .99 |
1.05 |
1.01 |
1.00 |
.97 |
.99 |
1.01 |
| ATP | .95 |
.98 |
1.06 |
1.05 |
.97 |
1.00 |
1.00 |
| KLA/ATP | 1.04 |
1.00 |
.95 |
1.05 |
.96 |
1.02 |
1.11 |
|
Cldn18 | |
NM_019815 |
claudin 18 (Cldn18), mRNA [NM_019815] |
KLA | .99 |
1.06 |
.99 |
.99 |
1.03 |
1.13 |
1.11 |
| ATP | .96 |
1.00 |
1.10 |
.98 |
.95 |
.98 |
1.07 |
| KLA/ATP | 1.07 |
.95 |
1.05 |
1.07 |
1.11 |
1.06 |
1.02 |
|
Cldn19 | |
NM_001038590 |
claudin 19 (Cldn19), transcript variant 1, mRNA [NM_001038590] |
KLA | 1.06 |
.92 |
1.01 |
1.01 |
1.03 |
.96 |
1.00 |
| ATP | 1.00 |
.97 |
1.05 |
.93 |
.95 |
.91 |
1.01 |
| KLA/ATP | .93 |
.99 |
.96 |
.93 |
.91 |
.92 |
.93 |
|
Cldn19 | |
NM_153105 |
claudin 19 (Cldn19), transcript variant 2, mRNA [NM_153105] |
KLA | .97 |
1.01 |
1.02 |
1.05 |
1.06 |
.96 |
1.09 |
| ATP | 1.04 |
.98 |
1.08 |
1.02 |
.98 |
1.00 |
.96 |
| KLA/ATP | 1.02 |
1.03 |
1.03 |
1.02 |
1.00 |
1.02 |
1.03 |
|
Cldn2 | |
NM_016675 |
claudin 2 (Cldn2), mRNA [NM_016675] |
KLA | .98 |
.93 |
1.02 |
1.04 |
1.00 |
1.03 |
1.01 |
| ATP | 1.01 |
1.01 |
1.00 |
1.06 |
1.01 |
.99 |
1.08 |
| KLA/ATP | 1.07 |
1.01 |
.72 |
1.04 |
1.04 |
1.04 |
1.00 |
|
Cldn22 | |
NM_029383 |
claudin 22 (Cldn22), mRNA [NM_029383] |
KLA | .99 |
.99 |
.99 |
.99 |
.99 |
.98 |
.96 |
| ATP | 1.01 |
.95 |
.99 |
.98 |
1.06 |
.92 |
.98 |
| KLA/ATP | 1.02 |
1.07 |
.96 |
1.00 |
1.02 |
1.04 |
.99 |
|
Cldn23 | |
NM_027998 |
claudin 23 (Cldn23), mRNA [NM_027998] |
KLA | 1.33 |
1.38 |
1.29 |
1.23 |
1.13 |
1.13 |
1.20 |
| ATP | .99 |
1.04 |
1.11 |
1.41 |
1.44 |
1.23 |
1.14 |
| KLA/ATP | 1.42 |
1.34 |
1.29 |
1.33 |
1.30 |
1.23 |
1.73 |
|
Cldn3 | |
NM_009902 |
claudin 3 (Cldn3), mRNA [NM_009902] |
KLA | 1.04 |
1.02 |
1.06 |
1.09 |
1.08 |
1.13 |
1.09 |
| ATP | 1.02 |
1.02 |
1.06 |
1.03 |
1.01 |
1.00 |
1.01 |
| KLA/ATP | 1.07 |
1.05 |
1.19 |
1.10 |
1.07 |
1.13 |
1.15 |
|
Cldn4 | |
NM_009903 |
claudin 4 (Cldn4), mRNA [NM_009903] |
KLA | 1.05 |
.99 |
.94 |
1.02 |
1.05 |
1.05 |
.98 |
| ATP | 1.01 |
1.04 |
1.01 |
.95 |
.96 |
1.09 |
1.09 |
| KLA/ATP | .98 |
1.11 |
1.08 |
1.05 |
.86 |
.95 |
1.07 |
|
Cldn5 | |
NM_013805 |
claudin 5 (Cldn5), mRNA [NM_013805] |
KLA | 1.08 |
1.08 |
1.23 |
1.13 |
1.16 |
1.18 |
1.18 |
| ATP | 1.01 |
1.02 |
1.03 |
1.03 |
1.05 |
1.00 |
1.06 |
| KLA/ATP | 1.14 |
1.18 |
1.13 |
1.09 |
1.05 |
1.15 |
1.16 |
|
Cldn6 | |
NM_018777 |
claudin 6 (Cldn6), mRNA [NM_018777] |
KLA | 1.06 |
1.04 |
.98 |
1.01 |
1.03 |
.99 |
.91 |
| ATP | .98 |
1.01 |
.94 |
.99 |
.95 |
1.14 |
1.07 |
| KLA/ATP | 1.02 |
.96 |
1.08 |
1.04 |
1.01 |
.95 |
1.05 |
|
Cldn7 | |
NM_016887 |
claudin 7 (Cldn7), mRNA [NM_016887] |
KLA | 1.21 |
1.23 |
1.33 |
1.38 |
1.44 |
1.26 |
1.01 |
| ATP | 1.01 |
1.01 |
1.07 |
1.01 |
1.04 |
1.04 |
1.03 |
| KLA/ATP | 1.22 |
1.28 |
1.24 |
2.23 |
1.42 |
1.17 |
1.07 |
|
Cldn8 | |
NM_018778 |
claudin 8 (Cldn8), mRNA [NM_018778] |
KLA | .98 |
.86 |
1.00 |
.98 |
1.02 |
1.06 |
.97 |
| ATP | .93 |
.99 |
1.01 |
1.00 |
1.05 |
1.01 |
1.03 |
| KLA/ATP | .98 |
1.08 |
.96 |
1.00 |
1.02 |
.98 |
1.00 |
|
Cldn9 | |
NM_020293 |
claudin 9 (Cldn9), mRNA [NM_020293] |
KLA | 1.29 |
1.24 |
1.37 |
1.34 |
1.32 |
1.37 |
1.55 |
| ATP | .92 |
.90 |
1.30 |
1.47 |
1.43 |
1.32 |
1.12 |
| KLA/ATP | 1.16 |
1.26 |
2.03 |
1.63 |
1.89 |
1.39 |
1.30 |
|
Crb3 | |
NM_177638 |
crumbs homolog 3 (Drosophila) (Crb3), mRNA [NM_177638] |
KLA | 1.00 |
.97 |
.98 |
1.00 |
1.01 |
.98 |
.94 |
| ATP | .97 |
.93 |
.94 |
1.00 |
.97 |
.93 |
.98 |
| KLA/ATP | .93 |
.97 |
1.02 |
.97 |
.93 |
.97 |
1.00 |
|
Csda | |
NM_011733 |
cold shock domain protein A (Csda), mRNA [NM_011733] |
KLA | 1.34 |
1.53 |
1.48 |
1.32 |
1.34 |
1.02 |
1.07 |
| ATP | 1.02 |
1.24 |
1.10 |
1.69 |
1.33 |
.90 |
.63 |
| KLA/ATP | 1.39 |
1.62 |
1.20 |
1.75 |
1.04 |
.88 |
.52 |
|
Csnk2a1 | |
NM_007788 |
casein kinase 2, alpha 1 polypeptide (Csnk2a1), mRNA [NM_007788] |
KLA | 1.36 |
1.39 |
1.19 |
1.34 |
1.32 |
1.74 |
1.86 |
| ATP | .92 |
.88 |
1.13 |
.86 |
1.12 |
2.50 |
1.99 |
| KLA/ATP | 1.19 |
1.24 |
1.35 |
1.03 |
1.16 |
2.09 |
2.88 |
|
Csnk2a2 | |
NM_009974 |
casein kinase 2, alpha prime polypeptide (Csnk2a2), mRNA [NM_009974] |
KLA | 1.46 |
1.53 |
1.70 |
1.47 |
1.32 |
1.32 |
1.17 |
| ATP | 1.00 |
1.11 |
1.17 |
1.33 |
1.71 |
2.03 |
1.06 |
| KLA/ATP | 1.58 |
1.67 |
1.69 |
2.00 |
2.20 |
2.44 |
1.68 |
|
Csnk2b | |
NM_009975 |
casein kinase 2, beta polypeptide (Csnk2b), mRNA [NM_009975] |
KLA | 1.19 |
1.10 |
1.12 |
1.13 |
1.20 |
1.28 |
1.25 |
| ATP | 1.12 |
1.03 |
1.04 |
1.07 |
1.20 |
1.27 |
1.09 |
| KLA/ATP | 1.15 |
1.20 |
1.25 |
1.13 |
1.44 |
1.34 |
1.35 |
|
Ctnna1 | |
AK008121 |
adult male small intestine cDNA, RIKEN full-length enriched library, clone:2010005H04 product:unclassifiable, full insert sequence. [AK008121] |
KLA | .82 |
.76 |
.72 |
.81 |
.94 |
.74 |
.80 |
| ATP | 1.08 |
1.01 |
.51 |
.57 |
2.45 |
1.25 |
.95 |
| KLA/ATP | .91 |
.82 |
.76 |
.58 |
1.58 |
1.01 |
.92 |
|
Ctnna1 | |
NM_009818 |
catenin (cadherin associated protein), alpha 1 (Ctnna1), mRNA [NM_009818] |
KLA | .97 |
.91 |
1.06 |
.84 |
.75 |
.52 |
.56 |
| ATP | 1.09 |
1.14 |
1.00 |
.86 |
.80 |
.98 |
.83 |
| KLA/ATP | 1.02 |
1.07 |
.90 |
.80 |
.66 |
.59 |
.57 |
|
Ctnna2 | |
AK035033 |
12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430076K22 product:hypothetical Vinculin and alpha-catenin containing protein, full insert sequence [AK035033] |
KLA | 1.05 |
1.11 |
1.12 |
1.05 |
1.02 |
1.04 |
1.19 |
| ATP | .99 |
.97 |
1.00 |
1.05 |
1.02 |
1.05 |
1.03 |
| KLA/ATP | 1.11 |
1.06 |
1.01 |
1.12 |
1.06 |
1.02 |
1.03 |
|
Ctnna3 | |
AK029664 |
adult male testis cDNA, RIKEN full-length enriched library, clone:4930438F12 product:unclassifiable, full insert sequence. [AK029664] |
KLA | 1.03 |
1.06 |
.99 |
1.05 |
.95 |
1.01 |
1.04 |
| ATP | 1.03 |
1.05 |
1.02 |
1.04 |
.99 |
1.03 |
1.05 |
| KLA/ATP | 1.01 |
1.00 |
.99 |
1.01 |
1.00 |
.98 |
1.05 |
|
Ctnna3 | |
NM_177612 |
catenin (cadherin associated protein), alpha 3 (Ctnna3), mRNA [NM_177612] |
KLA | 1.01 |
1.06 |
.98 |
1.04 |
1.03 |
1.04 |
1.07 |
| ATP | .96 |
1.02 |
.94 |
1.11 |
1.02 |
1.09 |
.91 |
| KLA/ATP | 1.01 |
.94 |
.94 |
1.10 |
1.10 |
1.04 |
1.04 |
|
Ctnnb1 | |
AK020013 |
adult male thymus cDNA, RIKEN full-length enriched library, clone:5830416C23 product:catenin beta, full insert sequence. [AK020013] |
KLA | 1.06 |
1.15 |
1.00 |
1.06 |
1.27 |
1.14 |
1.03 |
| ATP | .85 |
.57 |
1.74 |
3.36 |
4.13 |
2.19 |
1.55 |
| KLA/ATP | 1.12 |
.87 |
2.47 |
3.61 |
3.79 |
2.21 |
2.06 |
|
Ctnnb1 | |
NM_007614 |
catenin (cadherin associated protein), beta 1 (Ctnnb1), mRNA [NM_007614] |
KLA | 1.02 |
1.07 |
1.13 |
1.03 |
1.04 |
.93 |
.96 |
| ATP | 1.12 |
1.14 |
.75 |
.77 |
.73 |
.72 |
1.52 |
| KLA/ATP | 1.18 |
1.17 |
.77 |
.85 |
.60 |
.59 |
1.35 |
|
Cttn | |
NM_007803 |
cortactin (Cttn), mRNA [NM_007803] |
KLA | 1.12 |
1.14 |
1.28 |
1.32 |
1.64 |
2.25 |
2.00 |
| ATP | 1.04 |
1.02 |
.98 |
1.03 |
1.02 |
1.21 |
1.50 |
| KLA/ATP | 1.14 |
1.20 |
1.09 |
1.19 |
1.15 |
1.54 |
2.16 |
|
Epb4.1 | |
AK034678 |
12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430023J17 product:unclassifiable, full insert sequence [AK034678] |
KLA | .30 |
.28 |
.20 |
.16 |
.19 |
.36 |
.62 |
| ATP | .99 |
1.08 |
.87 |
.97 |
.57 |
.36 |
.68 |
| KLA/ATP | .30 |
.27 |
.18 |
.25 |
.36 |
.64 |
.92 |
|
Epb4.1 | |
NM_183428 |
erythrocyte protein band 4.1 (Epb4.1), mRNA [NM_183428] |
KLA | .53 |
.56 |
.46 |
.44 |
.44 |
.61 |
.79 |
| ATP | 1.09 |
1.20 |
.92 |
1.03 |
.67 |
.56 |
1.03 |
| KLA/ATP | .60 |
.56 |
.50 |
.53 |
.53 |
.81 |
1.38 |
|
Epb4.1l1
| |
NM_001003815 |
erythrocyte protein band 4.1-like 1 (Epb4.1l1), transcript variant 2, mRNA [NM_001003815] |
KLA | .73 |
.70 |
.59 |
.69 |
.82 |
1.21 |
1.03 |
| ATP | .96 |
.81 |
.57 |
.59 |
.59 |
.70 |
1.97 |
| KLA/ATP | .73 |
.64 |
.56 |
.53 |
.52 |
.65 |
1.85 |
|
Epb4.1l2
| |
NM_013511 |
erythrocyte protein band 4.1-like 2 (Epb4.1l2), mRNA [NM_013511] |
KLA | 1.09 |
1.14 |
1.11 |
.84 |
.71 |
.98 |
1.04 |
| ATP | 1.05 |
1.18 |
1.06 |
1.13 |
1.31 |
1.10 |
1.32 |
| KLA/ATP | 1.19 |
1.16 |
.97 |
1.03 |
1.07 |
1.15 |
1.28 |
|
Epb4.1l3
| |
AK086340 |
15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930022I19 product:unclassifiable, full insert sequence. [AK086340] |
KLA | 1.02 |
1.01 |
1.14 |
.96 |
1.03 |
1.02 |
.96 |
| ATP | .96 |
1.03 |
1.03 |
.94 |
.97 |
1.01 |
1.04 |
| KLA/ATP | .98 |
1.07 |
.94 |
.98 |
.95 |
.93 |
1.06 |
|
Epb4.1l3
| |
NM_013813 |
erythrocyte protein band 4.1-like 3 (Epb4.1l3), mRNA [NM_013813] |
KLA | 1.01 |
1.00 |
1.04 |
1.09 |
1.14 |
1.12 |
1.22 |
| ATP | 1.02 |
1.04 |
1.04 |
1.09 |
1.06 |
.98 |
1.04 |
| KLA/ATP | 1.06 |
.99 |
.93 |
1.19 |
1.07 |
1.14 |
1.20 |
|
Exoc3 | |
NM_177333 |
exocyst complex component 3 (Exoc3), mRNA [NM_177333] |
KLA | .84 |
.85 |
.91 |
.94 |
.98 |
.98 |
.88 |
| ATP | .94 |
.94 |
1.12 |
1.00 |
.63 |
.72 |
1.32 |
| KLA/ATP | .80 |
.83 |
.93 |
.89 |
.76 |
.75 |
1.10 |
|
Exoc4 | |
AK014499 |
14 days embryo liver cDNA, RIKEN full-length enriched library, clone:4432416A01 product:SEC8 (S. cerevisiae), full insert sequence. [AK014499] |
KLA | 1.12 |
1.15 |
1.08 |
1.02 |
.91 |
.78 |
.91 |
| ATP | 1.07 |
1.25 |
1.22 |
1.30 |
1.02 |
.80 |
.69 |
| KLA/ATP | 1.12 |
1.31 |
.96 |
1.02 |
.86 |
.75 |
.74 |
|
Exoc4 | |
AK038125 |
16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130080K06 product:SEC8 (S. cerevisiae), full insert sequence [AK038125] |
KLA | 1.00 |
.98 |
.87 |
.90 |
.97 |
.88 |
.76 |
| ATP | 1.03 |
1.12 |
.97 |
.74 |
.77 |
.83 |
.76 |
| KLA/ATP | .97 |
.85 |
.94 |
.74 |
.86 |
.74 |
.73 |
|
Exoc4 | |
NM_009148 |
exocyst complex component 4 (Exoc4), mRNA [NM_009148] |
KLA | 1.11 |
1.13 |
1.05 |
1.02 |
.96 |
.83 |
.56 |
| ATP | 1.06 |
1.08 |
.99 |
1.21 |
.93 |
.39 |
.51 |
| KLA/ATP | 1.17 |
1.15 |
1.14 |
1.21 |
.85 |
.45 |
.50 |
|
F11r | |
NM_172647 |
F11 receptor (F11r), mRNA [NM_172647] |
KLA | 7.81 |
8.47 |
6.77 |
8.24 |
6.97 |
3.97 |
1.27 |
| ATP | .91 |
.90 |
1.38 |
1.45 |
3.39 |
8.01 |
2.55 |
| KLA/ATP | 6.57 |
8.31 |
8.96 |
8.00 |
8.69 |
7.39 |
14.52 |
|
Gnai1 | |
NM_010305 |
guanine nucleotide binding protein (G protein), alpha inhibiting 1 (Gnai1), mRNA [NM_010305] |
KLA | .95 |
1.01 |
1.01 |
1.00 |
1.09 |
1.10 |
1.08 |
| ATP | 1.06 |
1.06 |
.99 |
1.15 |
1.02 |
.94 |
.99 |
| KLA/ATP | 1.02 |
1.04 |
.99 |
1.16 |
1.01 |
1.02 |
1.13 |
|
Gnai2 | |
NM_008138 |
guanine nucleotide binding protein (G protein), alpha inhibiting 2 (Gnai2), mRNA [NM_008138] |
KLA | .74 |
.79 |
.82 |
.74 |
.91 |
.97 |
1.10 |
| ATP | 1.07 |
1.16 |
.78 |
1.12 |
.78 |
.48 |
.82 |
| KLA/ATP | .91 |
.81 |
.53 |
.80 |
.60 |
.68 |
.87 |
|
Gnai3 | |
NM_010306 |
guanine nucleotide binding protein (G protein), alpha inhibiting 3 (Gnai3), mRNA [NM_010306] |
KLA | 1.23 |
1.24 |
1.14 |
1.06 |
.99 |
1.15 |
1.09 |
| ATP | .96 |
.93 |
.86 |
.64 |
1.34 |
2.02 |
1.35 |
| KLA/ATP | 1.20 |
1.24 |
.97 |
.76 |
1.21 |
1.62 |
1.17 |
|
Hcls1 | |
NM_008225 |
hematopoietic cell specific Lyn substrate 1 (Hcls1), mRNA [NM_008225] |
KLA | 1.40 |
1.40 |
1.33 |
1.57 |
2.01 |
2.26 |
2.51 |
| ATP | 1.12 |
1.08 |
.92 |
.87 |
.83 |
1.27 |
1.81 |
| KLA/ATP | 1.31 |
1.48 |
1.39 |
1.35 |
1.05 |
1.17 |
3.13 |
|
Hras1 | |
NM_008284 |
Harvey rat sarcoma virus oncogene 1 (Hras1), mRNA [NM_008284] |
KLA | .79 |
.82 |
.77 |
.82 |
.94 |
1.03 |
1.07 |
| ATP | 1.01 |
.95 |
.69 |
.83 |
.79 |
1.12 |
1.15 |
| KLA/ATP | .84 |
.77 |
.61 |
.65 |
.82 |
1.00 |
1.05 |
|
Igsf5 | |
NM_028078 |
immunoglobulin superfamily, member 5 (Igsf5), mRNA [NM_028078] |
KLA | .95 |
1.02 |
1.03 |
.98 |
1.03 |
1.04 |
1.10 |
| ATP | .96 |
.99 |
1.08 |
1.03 |
.97 |
.99 |
1.02 |
| KLA/ATP | 1.03 |
1.03 |
1.01 |
1.01 |
1.04 |
1.02 |
.96 |
|
Inadl | |
NM_001005784 |
InaD-like (Drosophila) (Inadl), transcript variant 2, mRNA [NM_001005784] |
KLA | .98 |
.95 |
1.00 |
.96 |
1.02 |
.99 |
1.00 |
| ATP | 1.00 |
.99 |
.94 |
.94 |
1.05 |
1.17 |
1.12 |
| KLA/ATP | 1.00 |
.95 |
.97 |
1.07 |
1.00 |
1.01 |
1.09 |
|
Inadl | |
NM_001005787 |
InaD-like (Drosophila) (Inadl), transcript variant 4, mRNA [NM_001005787] |
KLA | .98 |
.93 |
1.01 |
.88 |
.96 |
.89 |
.94 |
| ATP | 1.07 |
.97 |
.99 |
.96 |
1.01 |
1.58 |
.96 |
| KLA/ATP | 1.05 |
1.04 |
1.09 |
1.02 |
.93 |
1.72 |
2.21 |
|
Jam2 | |
NM_023844 |
junction adhesion molecule 2 (Jam2), mRNA [NM_023844] |
KLA | 1.84 |
2.17 |
1.88 |
1.76 |
1.69 |
1.51 |
1.46 |
| ATP | .97 |
.93 |
1.16 |
1.13 |
1.15 |
1.55 |
1.21 |
| KLA/ATP | 1.77 |
2.07 |
1.89 |
1.54 |
1.41 |
1.56 |
1.52 |
|
Jam3 | |
AK017692 |
8 days embryo whole body cDNA, RIKEN full-length enriched library, clone:5730470H08 product:junction cell adhesion molecule 3, full insert sequence. [AK017692] |
KLA | .94 |
1.00 |
1.01 |
1.00 |
1.02 |
1.00 |
.93 |
| ATP | .97 |
.99 |
1.03 |
.97 |
.98 |
.96 |
.94 |
| KLA/ATP | .94 |
1.04 |
.94 |
.91 |
.93 |
.87 |
1.03 |
|
Jam3 | |
NM_023277 |
junction adhesion molecule 3 (Jam3), mRNA [NM_023277] |
KLA | .97 |
1.02 |
1.06 |
1.06 |
1.01 |
.98 |
.74 |
| ATP | 1.07 |
1.00 |
.98 |
.96 |
.89 |
.88 |
.67 |
| KLA/ATP | 1.13 |
1.07 |
1.07 |
.97 |
.94 |
.91 |
.68 |
|
Kras | |
NM_021284 |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (Kras), mRNA [NM_021284] |
KLA | .53 |
.49 |
.40 |
.42 |
.49 |
.95 |
1.05 |
| ATP | .98 |
1.01 |
1.16 |
1.17 |
1.39 |
1.29 |
1.74 |
| KLA/ATP | .50 |
.47 |
.50 |
.56 |
1.00 |
1.24 |
1.58 |
|
Llgl1 | |
NM_008502 |
lethal giant larvae homolog 1 (Drosophila) (Llgl1), mRNA [NM_008502] |
KLA | 1.38 |
1.33 |
1.49 |
1.35 |
1.13 |
1.21 |
1.09 |
| ATP | .97 |
1.01 |
.95 |
.85 |
.77 |
1.31 |
1.32 |
| KLA/ATP | 1.31 |
1.43 |
1.28 |
1.21 |
1.04 |
1.38 |
1.57 |
|
Llgl2 | |
NM_145438 |
lethal giant larvae homolog 2 (Drosophila) (Llgl2), mRNA [NM_145438] |
KLA | .79 |
.70 |
.69 |
.79 |
.97 |
.98 |
1.19 |
| ATP | 1.06 |
1.13 |
.92 |
.90 |
1.16 |
1.79 |
1.33 |
| KLA/ATP | .84 |
.71 |
.73 |
.69 |
.81 |
1.58 |
1.39 |
|
LOC10004 6483 | |
XM_001476285 |
ref|PREDICTED: Mus musculus similar to casein kinase II, alpha prime subunit (LOC100046483), mRNA [XM_001476285] |
KLA | .97 |
.94 |
.94 |
.88 |
.84 |
.76 |
.88 |
| ATP | 1.06 |
1.04 |
.89 |
.82 |
.87 |
.70 |
.56 |
| KLA/ATP | 1.03 |
1.00 |
.88 |
.75 |
.73 |
.66 |
.43 |
|
Magi1 | |
NM_001083321 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 (Magi1), transcript variant 4, mRNA [NM_001083321] |
KLA | 1.03 |
.99 |
1.02 |
.98 |
1.03 |
.96 |
.97 |
| ATP | .97 |
1.01 |
.96 |
.89 |
1.03 |
.86 |
.94 |
| KLA/ATP | 1.01 |
1.02 |
1.06 |
.97 |
.95 |
.97 |
.95 |
|
Magi1 | |
NM_010367 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 (Magi1), transcript variant 1, mRNA [NM_010367] |
KLA | 1.05 |
.91 |
.92 |
.91 |
.86 |
.77 |
.67 |
| ATP | .99 |
.90 |
1.12 |
.93 |
.96 |
.86 |
.81 |
| KLA/ATP | .85 |
.85 |
.94 |
.84 |
.83 |
.78 |
.70 |
|
Magi2 | |
NM_015823 |
membrane associated guanylate kinase, WW and PDZ domain containing 2 (Magi2), mRNA [NM_015823] |
KLA | .70 |
.66 |
.52 |
.64 |
.62 |
.68 |
.87 |
| ATP | .61 |
.56 |
.48 |
.54 |
.53 |
.81 |
.72 |
| KLA/ATP | .44 |
.46 |
.40 |
.49 |
.47 |
.57 |
.54 |
|
Magi3 | |
AK173225 |
premature mRNA for mKIAA1634 protein [AK173225] |
KLA | 1.22 |
1.16 |
1.12 |
1.00 |
.75 |
.75 |
.80 |
| ATP | .94 |
.79 |
.89 |
.98 |
1.50 |
1.27 |
.90 |
| KLA/ATP | 1.24 |
1.01 |
.90 |
.88 |
1.15 |
1.21 |
1.17 |
|
Magi3 | |
NM_133853 |
membrane associated guanylate kinase, WW and PDZ domain containing 3 (Magi3), mRNA [NM_133853] |
KLA | 1.01 |
.99 |
1.03 |
.98 |
.91 |
.92 |
.96 |
| ATP | 1.07 |
.91 |
.83 |
.87 |
1.19 |
1.04 |
.94 |
| KLA/ATP | 1.04 |
1.06 |
.90 |
.90 |
.90 |
1.00 |
1.03 |
|
Mllt4 | |
NM_010806 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 (Mllt4), mRNA [NM_010806] |
KLA | .70 |
.66 |
.57 |
.68 |
.70 |
.66 |
.82 |
| ATP | 1.03 |
1.01 |
1.05 |
.96 |
.76 |
.91 |
1.15 |
| KLA/ATP | .65 |
.68 |
.66 |
.54 |
.82 |
1.14 |
1.10 |
|
Mm.10799 6 | |
94407580 |
Unknown |
KLA | .97 |
.95 |
.93 |
1.00 |
.95 |
1.00 |
1.00 |
| ATP | .95 |
1.03 |
.96 |
.92 |
1.03 |
.93 |
1.05 |
| KLA/ATP | .99 |
.91 |
.97 |
.92 |
.90 |
.90 |
.92 |
|
Mm.13075 2 | |
76096373 |
Unknown |
KLA | 1.29 |
1.10 |
1.11 |
1.17 |
1.19 |
1.30 |
1.11 |
| ATP | 1.13 |
.92 |
1.53 |
1.42 |
1.93 |
2.06 |
1.21 |
| KLA/ATP | 1.22 |
1.23 |
1.76 |
1.36 |
2.11 |
1.90 |
1.77 |
|
Mm.15909 3 | |
149272242 |
Unknown |
KLA | 1.01 |
.97 |
1.01 |
1.01 |
1.05 |
1.02 |
.99 |
| ATP | 1.04 |
1.01 |
.95 |
1.02 |
.99 |
.94 |
.96 |
| KLA/ATP | .96 |
1.01 |
1.04 |
.94 |
.94 |
1.05 |
.98 |
|
Mm.23692
| |
164565453 |
Unknown |
KLA | .83 |
.77 |
.72 |
.65 |
.61 |
.75 |
.80 |
| ATP | .77 |
.94 |
1.03 |
.63 |
.61 |
.74 |
.59 |
| KLA/ATP | .58 |
.78 |
.77 |
.52 |
.51 |
.56 |
.30 |
|
Mm.25070 5 | |
7305294 |
Unknown |
KLA | 1.01 |
1.06 |
1.00 |
1.05 |
.99 |
1.07 |
.99 |
| ATP | 1.00 |
1.05 |
1.06 |
1.03 |
.89 |
1.01 |
1.10 |
| KLA/ATP | 1.04 |
.92 |
1.05 |
1.07 |
1.00 |
1.00 |
1.05 |
|
Mm.26132 9 | |
71037402 |
Unknown |
KLA | 1.53 |
1.44 |
1.59 |
1.66 |
1.72 |
1.88 |
1.09 |
| ATP | 1.08 |
.98 |
1.38 |
1.35 |
1.28 |
1.25 |
1.07 |
| KLA/ATP | 1.49 |
1.53 |
1.97 |
1.61 |
1.54 |
1.25 |
1.08 |
|
Mm.27604 2 | |
18702319 |
Unknown |
KLA | .81 |
.72 |
.70 |
.70 |
.54 |
.54 |
.67 |
| ATP | .90 |
.95 |
1.17 |
1.15 |
1.35 |
1.32 |
1.13 |
| KLA/ATP | .70 |
.78 |
.89 |
.83 |
1.09 |
1.13 |
.97 |
|
Mm.41758
| |
148747503 |
Unknown |
KLA | 1.68 |
1.98 |
1.80 |
1.70 |
1.53 |
1.43 |
1.42 |
| ATP | 1.05 |
1.08 |
1.12 |
1.06 |
1.09 |
1.51 |
1.15 |
| KLA/ATP | 1.74 |
2.06 |
1.81 |
1.45 |
1.47 |
1.42 |
1.55 |
|
Mm.44128 3 | |
149253604 |
Unknown |
KLA | .66 |
.64 |
.61 |
.67 |
.60 |
.72 |
.88 |
| ATP | .71 |
.62 |
.69 |
.55 |
.46 |
.66 |
.70 |
| KLA/ATP | .58 |
.48 |
.57 |
.49 |
.50 |
.52 |
.55 |
|
Mm.45680 7 | |
157951728 |
Unknown |
KLA | 1.00 |
1.02 |
1.05 |
.97 |
.99 |
.96 |
1.05 |
| ATP | 1.13 |
.98 |
1.00 |
1.06 |
1.02 |
.94 |
.98 |
| KLA/ATP | 1.11 |
.96 |
1.08 |
1.01 |
.99 |
1.01 |
.98 |
|
Mm.45798 3 | |
118131045 |
Unknown |
KLA | .95 |
1.08 |
1.17 |
1.13 |
1.10 |
1.13 |
1.06 |
| ATP | 1.02 |
.97 |
1.03 |
1.07 |
1.17 |
1.22 |
1.05 |
| KLA/ATP | 1.04 |
1.05 |
1.06 |
1.11 |
1.41 |
1.49 |
1.08 |
|
Mm.46514
| |
114326498 |
Unknown |
KLA | 1.06 |
.98 |
1.04 |
.98 |
1.00 |
.99 |
.99 |
| ATP | 1.03 |
.95 |
1.00 |
.93 |
1.00 |
1.00 |
.98 |
| KLA/ATP | 1.06 |
.99 |
.94 |
.95 |
.90 |
.91 |
1.02 |
|
Mpdz | |
AK051782 |
12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130079L03 product:multiple PDZ domain protein, full insert sequence. [AK051782] |
KLA | .97 |
1.02 |
1.07 |
1.00 |
.99 |
1.05 |
1.07 |
| ATP | .97 |
1.04 |
1.01 |
1.04 |
1.00 |
1.13 |
1.02 |
| KLA/ATP | .99 |
.99 |
.98 |
1.07 |
1.05 |
1.20 |
1.06 |
|
Mpdz | |
NM_010820 |
multiple PDZ domain protein (Mpdz), mRNA [NM_010820] |
KLA | .99 |
.99 |
.98 |
.99 |
1.00 |
1.00 |
.97 |
| ATP | 1.01 |
1.00 |
1.09 |
.98 |
.99 |
1.03 |
.99 |
| KLA/ATP | .98 |
1.00 |
1.06 |
1.01 |
1.02 |
.96 |
.97 |
|
Mpp5 | |
BC075698 |
cDNA clone IMAGE:30640755, containing frame-shift errors [BC075698] |
KLA | .93 |
.87 |
.79 |
.68 |
.81 |
.96 |
.97 |
| ATP | 1.01 |
1.08 |
.92 |
.93 |
3.29 |
2.21 |
1.39 |
| KLA/ATP | .94 |
.91 |
.76 |
.73 |
1.80 |
2.16 |
1.38 |
|
Mpp5 | |
NM_019579 |
membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5) (Mpp5), mRNA [NM_019579] |
KLA | .93 |
.90 |
.81 |
.78 |
.84 |
.93 |
.93 |
| ATP | 1.06 |
1.09 |
.97 |
1.09 |
3.90 |
2.42 |
1.49 |
| KLA/ATP | 1.04 |
.97 |
.86 |
.84 |
2.23 |
2.20 |
1.39 |
|
Mras | |
NM_008624 |
muscle and microspikes RAS (Mras), mRNA [NM_008624] |
KLA | .77 |
.76 |
.75 |
.84 |
.92 |
.87 |
1.35 |
| ATP | 1.02 |
1.00 |
1.11 |
1.14 |
.87 |
.79 |
.80 |
| KLA/ATP | .77 |
.77 |
.86 |
.78 |
.69 |
.63 |
.61 |
|
Myh1 | |
AK009974 |
adult male tongue cDNA, RIKEN full-length enriched library, clone:2310058C22 product:myosin, heavy polypeptide 1, skeletal muscle, adult, full insert sequence [AK009974] |
KLA | .98 |
.99 |
.95 |
1.03 |
.98 |
.98 |
.98 |
| ATP | .98 |
1.00 |
1.02 |
1.00 |
.99 |
1.01 |
.99 |
| KLA/ATP | .98 |
.95 |
1.05 |
1.06 |
1.01 |
1.00 |
1.06 |
|
Myh1 | |
NM_030679 |
myosin, heavy polypeptide 1, skeletal muscle, adult (Myh1), mRNA [NM_030679] |
KLA | 1.04 |
.99 |
.98 |
1.04 |
1.04 |
1.00 |
1.05 |
| ATP | .95 |
1.02 |
1.09 |
1.02 |
.98 |
1.03 |
1.06 |
| KLA/ATP | 1.02 |
.98 |
1.05 |
1.01 |
.96 |
1.00 |
.99 |
|
Myh10 | |
NM_175260 |
myosin, heavy polypeptide 10, non-muscle (Myh10), mRNA [NM_175260] |
KLA | 1.04 |
1.08 |
1.24 |
1.13 |
1.13 |
1.02 |
.77 |
| ATP | 1.06 |
1.09 |
1.04 |
1.04 |
.94 |
.84 |
.79 |
| KLA/ATP | 1.09 |
1.16 |
1.08 |
1.05 |
1.05 |
.88 |
.75 |
|
Myh11 | |
NM_013607 |
myosin, heavy polypeptide 11, smooth muscle (Myh11), mRNA [NM_013607] |
KLA | 1.01 |
1.05 |
1.02 |
1.06 |
1.00 |
.96 |
1.01 |
| ATP | 1.09 |
.98 |
1.00 |
1.00 |
1.03 |
.97 |
1.13 |
| KLA/ATP | .99 |
1.06 |
1.05 |
1.03 |
.98 |
1.05 |
1.10 |
|
Myh13 | |
NM_001081250 |
myosin, heavy polypeptide 13, skeletal muscle (Myh13), mRNA [NM_001081250] |
KLA | 1.01 |
1.04 |
1.01 |
.99 |
1.00 |
1.06 |
.97 |
| ATP | .99 |
1.02 |
1.05 |
1.08 |
.99 |
.98 |
1.01 |
| KLA/ATP | 1.01 |
.98 |
.99 |
1.02 |
1.06 |
1.00 |
1.01 |
|
Myh14 | |
NM_028021 |
myosin, heavy polypeptide 14 (Myh14), mRNA [NM_028021] |
KLA | 1.10 |
1.12 |
1.05 |
1.07 |
1.10 |
1.06 |
1.07 |
| ATP | 1.02 |
1.04 |
1.03 |
1.02 |
1.01 |
1.04 |
1.10 |
| KLA/ATP | 1.02 |
1.07 |
1.06 |
1.04 |
1.13 |
1.10 |
1.13 |
|
Myh2 | |
AK036437 |
adult male bone cDNA, RIKEN full-length enriched library, clone:9830108D13 product:SIMILAR TO MYOSIN, HEAVY POLYPEPTIDE 2, SKELETAL MUSCLE, ADULT homolog [Mus musculus], full insert sequence. [AK036437] |
KLA | .97 |
1.04 |
1.02 |
1.02 |
.95 |
1.02 |
.95 |
| ATP | 1.00 |
.98 |
1.05 |
1.00 |
.95 |
1.08 |
.97 |
| KLA/ATP | .95 |
1.00 |
.94 |
.99 |
.95 |
.98 |
.99 |
|
Myh2 | |
NM_001039545 |
myosin, heavy polypeptide 2, skeletal muscle, adult (Myh2), mRNA [NM_001039545] |
KLA | .99 |
.98 |
1.03 |
1.02 |
.98 |
.98 |
1.01 |
| ATP | 1.01 |
.98 |
.98 |
1.01 |
.97 |
.99 |
.95 |
| KLA/ATP | .95 |
1.00 |
1.05 |
1.00 |
.96 |
.99 |
1.02 |
|
Myh3 | |
NM_001099635 |
myosin, heavy polypeptide 3, skeletal muscle, embryonic (Myh3), mRNA [NM_001099635] |
KLA | 1.01 |
.97 |
.95 |
1.07 |
1.08 |
1.08 |
1.07 |
| ATP | 1.02 |
.97 |
.98 |
1.02 |
.94 |
.96 |
1.09 |
| KLA/ATP | 1.03 |
1.05 |
1.03 |
1.17 |
1.73 |
2.01 |
1.22 |
|
Myh4 | |
NM_010855 |
myosin, heavy polypeptide 4, skeletal muscle (Myh4), mRNA [NM_010855] |
KLA | 1.06 |
1.00 |
1.00 |
1.02 |
1.06 |
1.06 |
1.01 |
| ATP | .99 |
1.04 |
1.02 |
.98 |
.96 |
1.02 |
1.06 |
| KLA/ATP | 1.01 |
1.00 |
1.00 |
1.04 |
.99 |
1.00 |
1.03 |
|
Myh6 | |
NM_010856 |
myosin, heavy polypeptide 6, cardiac muscle, alpha (Myh6), mRNA [NM_010856] |
KLA | 1.00 |
1.01 |
1.00 |
.99 |
1.00 |
.98 |
1.02 |
| ATP | 1.00 |
.99 |
.96 |
.98 |
1.01 |
1.01 |
.98 |
| KLA/ATP | 1.03 |
1.04 |
1.01 |
1.01 |
.99 |
1.00 |
1.02 |
|
Myh7 | |
NM_080728 |
myosin, heavy polypeptide 7, cardiac muscle, beta (Myh7), mRNA [NM_080728] |
KLA | 1.06 |
1.13 |
1.14 |
1.07 |
1.09 |
1.06 |
1.03 |
| ATP | .96 |
1.01 |
1.09 |
1.05 |
1.15 |
1.16 |
1.12 |
| KLA/ATP | 1.01 |
1.05 |
1.02 |
.98 |
1.29 |
1.62 |
1.09 |
|
Myh8 | |
NM_177369 |
myosin, heavy polypeptide 8, skeletal muscle, perinatal (Myh8), mRNA [NM_177369] |
KLA | 1.03 |
.98 |
1.04 |
.99 |
1.02 |
.99 |
.97 |
| ATP | 1.06 |
1.07 |
.97 |
.99 |
.98 |
.98 |
1.01 |
| KLA/ATP | 1.11 |
1.11 |
1.05 |
1.03 |
.98 |
1.07 |
.95 |
|
Myh9 | |
NM_022410 |
myosin, heavy polypeptide 9, non-muscle (Myh9), transcript variant 1, mRNA [NM_022410] |
KLA | .69 |
.65 |
.55 |
.57 |
.70 |
1.14 |
.82 |
| ATP | .91 |
.98 |
1.08 |
.80 |
.77 |
.99 |
.84 |
| KLA/ATP | .62 |
.66 |
.69 |
.49 |
.47 |
.54 |
.70 |
|
Myl2 | |
NM_010861 |
myosin, light polypeptide 2, regulatory, cardiac, slow (Myl2), mRNA [NM_010861] |
KLA | .88 |
.93 |
.94 |
.95 |
.94 |
.77 |
.60 |
| ATP | .96 |
1.04 |
1.14 |
1.06 |
1.00 |
.93 |
.66 |
| KLA/ATP | .91 |
.85 |
1.07 |
1.03 |
.88 |
.79 |
.67 |
|
Myl7 | |
NM_022879 |
myosin, light polypeptide 7, regulatory (Myl7), mRNA [NM_022879] |
KLA | .95 |
1.01 |
1.02 |
.97 |
1.00 |
1.04 |
1.01 |
| ATP | 1.01 |
1.02 |
.96 |
.98 |
1.00 |
.98 |
1.01 |
| KLA/ATP | .98 |
1.06 |
1.03 |
.97 |
.85 |
1.01 |
1.00 |
|
Mylc2b | |
NM_023402 |
myosin light chain, regulatory B (Mylc2b), mRNA [NM_023402] |
KLA | .88 |
.84 |
.82 |
.86 |
.84 |
1.03 |
1.08 |
| ATP | .97 |
1.02 |
1.12 |
1.24 |
.96 |
.83 |
1.23 |
| KLA/ATP | .84 |
.83 |
.87 |
.97 |
.86 |
.91 |
1.34 |
|
Mylc2pl | |
NM_021611 |
myosin light chain 2, precursor lymphocyte-specific (Mylc2pl), transcript variant 1, mRNA [NM_021611] |
KLA | .99 |
.97 |
.93 |
1.05 |
1.00 |
1.03 |
1.00 |
| ATP | .99 |
1.01 |
1.03 |
1.03 |
.98 |
.97 |
1.06 |
| KLA/ATP | .97 |
1.03 |
.93 |
1.01 |
.97 |
1.05 |
1.05 |
|
Mylpf | |
NM_016754 |
myosin light chain, phosphorylatable, fast skeletal muscle (Mylpf), mRNA [NM_016754] |
KLA | 1.07 |
1.12 |
1.08 |
1.20 |
1.17 |
1.27 |
1.34 |
| ATP | 1.00 |
.90 |
.98 |
1.08 |
.98 |
1.22 |
1.09 |
| KLA/ATP | 1.00 |
1.15 |
1.14 |
1.18 |
1.18 |
1.04 |
1.19 |
|
Nras | |
NM_010937 |
neuroblastoma ras oncogene (Nras), mRNA [NM_010937] |
KLA | 1.20 |
1.22 |
1.27 |
1.20 |
1.09 |
.91 |
.84 |
| ATP | .98 |
.91 |
.69 |
.61 |
.59 |
.67 |
.78 |
| KLA/ATP | 1.22 |
1.14 |
.97 |
.79 |
.73 |
.61 |
.72 |
|
Ocln | |
NM_008756 |
occludin (Ocln), mRNA [NM_008756] |
KLA | 1.02 |
1.04 |
1.03 |
1.03 |
.99 |
1.05 |
1.00 |
| ATP | 1.03 |
.98 |
1.01 |
1.07 |
1.05 |
1.05 |
1.04 |
| KLA/ATP | 1.09 |
1.00 |
1.03 |
1.05 |
1.06 |
1.03 |
1.01 |
|
Pard3 | |
AK076429 |
0 day neonate head cDNA, RIKEN full-length enriched library, clone:4832405A21 product:par-3 (partitioning defective 3) homolog (C. elegans), full insert sequence. [AK076429] |
KLA | .96 |
.96 |
1.03 |
.96 |
1.03 |
.99 |
1.19 |
| ATP | .97 |
.92 |
1.09 |
.99 |
1.00 |
1.03 |
.94 |
| KLA/ATP | .97 |
1.01 |
.97 |
1.05 |
.98 |
.92 |
1.04 |
|
Pard3 | |
NM_001013580 |
par-3 (partitioning defective 3) homolog (C. elegans) (Pard3), transcript variant 2, mRNA [NM_001013580] |
KLA | 1.02 |
.99 |
1.03 |
.97 |
1.00 |
.97 |
1.04 |
| ATP | .93 |
1.02 |
.98 |
.95 |
1.02 |
1.02 |
.98 |
| KLA/ATP | 1.04 |
.98 |
1.01 |
.99 |
.96 |
.91 |
.95 |
|
Pard3 | |
NM_001013581 |
par-3 (partitioning defective 3) homolog (C. elegans) (Pard3), transcript variant 1, mRNA [NM_001013581] |
KLA | .99 |
1.06 |
1.02 |
1.02 |
1.00 |
.98 |
.95 |
| ATP | .91 |
1.05 |
1.06 |
.99 |
1.04 |
.89 |
.99 |
| KLA/ATP | .98 |
.97 |
1.09 |
.97 |
1.01 |
.98 |
1.00 |
|
Pard3 | |
NM_001122850 |
par-3 (partitioning defective 3) homolog (C. elegans) (Pard3), transcript variant 4, mRNA [NM_001122850] |
KLA | 1.01 |
.95 |
1.00 |
1.01 |
1.07 |
.91 |
.99 |
| ATP | 1.00 |
1.01 |
.98 |
.94 |
1.04 |
.98 |
1.00 |
| KLA/ATP | .99 |
.99 |
1.04 |
1.04 |
1.04 |
1.01 |
1.03 |
|
Pard3 | |
NM_033620 |
par-3 (partitioning defective 3) homolog (C. elegans) (Pard3), transcript variant 3, mRNA [NM_033620] |
KLA | .92 |
.93 |
.97 |
.96 |
1.00 |
.99 |
1.02 |
| ATP | 1.08 |
1.03 |
.93 |
.92 |
.99 |
.97 |
1.00 |
| KLA/ATP | .99 |
1.03 |
1.02 |
1.05 |
.96 |
1.06 |
1.03 |
|
Pard6a | |
NM_001047436 |
par-6 (partitioning defective 6,) homolog alpha (C. elegans) (Pard6a), transcript variant 3, mRNA [NM_001047436] |
KLA | .85 |
.86 |
.99 |
1.14 |
1.22 |
1.22 |
1.02 |
| ATP | 1.17 |
1.16 |
1.11 |
1.14 |
.92 |
1.12 |
1.29 |
| KLA/ATP | .84 |
.88 |
1.14 |
1.20 |
1.22 |
1.32 |
1.26 |
|
Pard6b | |
BC025147 |
par-6 (partitioning defective 6) homolog beta (C. elegans), mRNA (cDNA clone MGC:35871 IMAGE:2655658), complete cds [BC025147] |
KLA | .97 |
.97 |
.91 |
.92 |
.92 |
.95 |
.97 |
| ATP | .97 |
.99 |
.99 |
.99 |
1.10 |
1.02 |
1.10 |
| KLA/ATP | .99 |
.97 |
.96 |
.95 |
1.10 |
1.11 |
1.13 |
|
Pard6b | |
NM_021409 |
par-6 (partitioning defective 6) homolog beta (C. elegans) (Pard6b), mRNA [NM_021409] |
KLA | .96 |
1.04 |
.96 |
1.03 |
.98 |
1.07 |
1.04 |
| ATP | 1.00 |
.92 |
1.02 |
1.01 |
.97 |
1.01 |
.98 |
| KLA/ATP | 1.02 |
.92 |
1.03 |
1.02 |
1.01 |
.97 |
1.01 |
|
Pard6g | |
AK019835 |
adult male testis cDNA, RIKEN full-length enriched library, clone:4930590G08 product:unclassifiable, full insert sequence. [AK019835] |
KLA | .95 |
.95 |
.84 |
.86 |
.78 |
.80 |
.76 |
| ATP | 1.01 |
.94 |
1.00 |
.88 |
.84 |
.89 |
.73 |
| KLA/ATP | .90 |
.87 |
.87 |
.81 |
.82 |
.73 |
.73 |
|
Pard6g | |
NM_053117 |
par-6 partitioning defective 6 homolog gamma (C. elegans) (Pard6g), mRNA [NM_053117] |
KLA | .92 |
.83 |
.73 |
.69 |
.56 |
.68 |
.57 |
| ATP | .98 |
.89 |
.92 |
.83 |
.69 |
.80 |
.56 |
| KLA/ATP | .86 |
.81 |
.72 |
.73 |
.66 |
.70 |
.53 |
|
Ppp2ca | |
NM_019411 |
protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform (Ppp2ca), mRNA [NM_019411] |
KLA | 1.17 |
1.13 |
1.18 |
1.20 |
1.54 |
1.45 |
1.34 |
| ATP | 1.09 |
1.20 |
1.07 |
1.33 |
1.56 |
2.04 |
1.43 |
| KLA/ATP | 1.14 |
1.17 |
1.15 |
1.49 |
1.59 |
2.37 |
2.02 |
|
Ppp2cb | |
NM_017374 |
protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform (Ppp2cb), mRNA [NM_017374] |
KLA | 1.32 |
1.33 |
1.37 |
1.24 |
1.27 |
1.09 |
1.18 |
| ATP | .94 |
.93 |
.82 |
.91 |
1.22 |
2.01 |
1.08 |
| KLA/ATP | 1.24 |
1.14 |
.80 |
.97 |
1.13 |
1.54 |
1.18 |
|
Ppp2r1a | |
NM_016891 |
protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), alpha isoform (Ppp2r1a), mRNA [NM_016891] |
KLA | 1.44 |
1.39 |
1.47 |
1.37 |
1.69 |
1.33 |
1.16 |
| ATP | 1.18 |
1.55 |
.85 |
1.67 |
1.38 |
.99 |
1.24 |
| KLA/ATP | 1.66 |
1.98 |
.97 |
2.33 |
1.41 |
1.65 |
1.38 |
|
Ppp2r1b | |
NM_001034085 |
protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), beta isoform (Ppp2r1b), transcript variant 1, mRNA [NM_001034085] |
KLA | 1.26 |
1.17 |
1.14 |
1.13 |
1.12 |
1.11 |
.99 |
| ATP | .90 |
.90 |
.96 |
.98 |
1.59 |
1.71 |
1.16 |
| KLA/ATP | 1.23 |
1.16 |
.99 |
1.00 |
1.54 |
1.34 |
1.24 |
|
Ppp2r1b | |
NM_028614 |
protein phosphatase 2 (formerly 2A), regulatory subunit A (PR 65), beta isoform (Ppp2r1b), transcript variant 2, mRNA [NM_028614] |
KLA | 2.38 |
2.38 |
2.53 |
1.80 |
1.52 |
.95 |
1.16 |
| ATP | 1.17 |
1.29 |
1.04 |
1.09 |
1.16 |
1.19 |
1.00 |
| KLA/ATP | 2.59 |
2.78 |
1.82 |
2.31 |
1.34 |
1.03 |
.75 |
|
Ppp2r2a | |
NM_028032 |
protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), alpha isoform (Ppp2r2a), mRNA [NM_028032] |
KLA | 2.18 |
2.42 |
2.58 |
2.17 |
2.08 |
1.83 |
1.57 |
| ATP | 1.06 |
1.12 |
.90 |
1.28 |
1.76 |
1.70 |
1.39 |
| KLA/ATP | 2.55 |
2.38 |
1.62 |
2.68 |
2.25 |
2.55 |
1.86 |
|
Ppp2r2b | |
AK086561 |
15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930037C08 product:unclassifiable, full insert sequence [AK086561] |
KLA | .94 |
1.02 |
1.07 |
1.02 |
1.02 |
.97 |
.98 |
| ATP | 1.01 |
1.04 |
1.01 |
.99 |
.97 |
.95 |
1.00 |
| KLA/ATP | 1.04 |
1.06 |
1.01 |
.96 |
1.02 |
.90 |
.93 |
|
Ppp2r2b | |
NM_028392 |
protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), beta isoform (Ppp2r2b), transcript variant 2, mRNA [NM_028392] |
KLA | 1.01 |
1.02 |
.96 |
1.00 |
1.04 |
1.01 |
1.00 |
| ATP | 1.00 |
.96 |
1.07 |
.93 |
.95 |
1.01 |
1.03 |
| KLA/ATP | .95 |
1.01 |
1.06 |
1.07 |
.98 |
1.02 |
1.03 |
|
Ppp2r2c | |
NM_172994 |
protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), gamma isoform (Ppp2r2c), mRNA [NM_172994] |
KLA | .97 |
.98 |
.96 |
1.02 |
1.02 |
1.06 |
1.01 |
| ATP | .96 |
1.05 |
1.03 |
.98 |
1.01 |
1.04 |
1.06 |
| KLA/ATP | .98 |
.98 |
1.00 |
.96 |
1.00 |
.86 |
1.10 |
|
Ppp2r2d | |
NM_026391 |
protein phosphatase 2, regulatory subunit B, delta isoform (Ppp2r2d), mRNA [NM_026391] |
KLA | 1.07 |
1.03 |
1.14 |
1.18 |
1.16 |
1.27 |
1.13 |
| ATP | .96 |
.93 |
.95 |
.76 |
1.34 |
2.21 |
1.22 |
| KLA/ATP | 1.01 |
1.01 |
1.01 |
.87 |
1.91 |
2.19 |
2.18 |
|
Prkca | |
NM_011101 |
protein kinase C, alpha (Prkca), mRNA [NM_011101] |
KLA | 1.00 |
.96 |
.94 |
.95 |
.95 |
.89 |
.96 |
| ATP | 1.00 |
1.03 |
.91 |
.94 |
.82 |
.87 |
1.13 |
| KLA/ATP | 1.02 |
.95 |
.91 |
.86 |
.78 |
.84 |
.94 |
|
Prkcb1 | |
NM_008855 |
protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855] |
KLA | .92 |
.95 |
.93 |
.78 |
.77 |
1.08 |
1.83 |
| ATP | 1.03 |
1.12 |
1.09 |
1.23 |
.90 |
2.08 |
.96 |
| KLA/ATP | .98 |
.99 |
.82 |
.89 |
.62 |
1.01 |
1.08 |
|
Prkcc | |
NM_011102 |
protein kinase C, gamma (Prkcc), mRNA [NM_011102] |
KLA | 1.02 |
1.04 |
1.11 |
1.04 |
.96 |
1.02 |
1.05 |
| ATP | .98 |
.98 |
1.05 |
1.03 |
1.08 |
.96 |
.95 |
| KLA/ATP | 1.21 |
1.16 |
1.09 |
1.07 |
1.04 |
.98 |
.93 |
|
Prkcd | |
NM_011103 |
protein kinase C, delta (Prkcd), mRNA [NM_011103] |
KLA | 1.72 |
1.84 |
1.90 |
1.68 |
2.01 |
1.61 |
1.64 |
| ATP | 1.00 |
1.03 |
.68 |
.81 |
1.38 |
1.26 |
.98 |
| KLA/ATP | 1.77 |
1.79 |
1.16 |
1.19 |
1.33 |
1.25 |
1.56 |
|
Prkce | |
AK017901 |
adult male thymus cDNA, RIKEN full-length enriched library, clone:5830406C15 product:unclassifiable, full insert sequence. [AK017901] |
KLA | 1.63 |
1.44 |
1.95 |
2.09 |
1.96 |
1.34 |
1.56 |
| ATP | .99 |
.83 |
.85 |
.78 |
.85 |
2.44 |
1.47 |
| KLA/ATP | 1.36 |
1.45 |
1.44 |
1.23 |
1.30 |
2.39 |
2.29 |
|
Prkce | |
AK042994 |
7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730046G04 product:protein kinase C, epsilon, full insert sequence. [AK042994] |
KLA | 1.01 |
1.07 |
1.03 |
1.03 |
1.04 |
1.00 |
1.06 |
| ATP | .99 |
1.09 |
1.08 |
1.05 |
1.02 |
1.06 |
1.07 |
| KLA/ATP | 1.00 |
.90 |
1.06 |
1.14 |
1.10 |
1.08 |
1.09 |
|
Prkch | |
NM_008856 |
protein kinase C, eta (Prkch), mRNA [NM_008856] |
KLA | .17 |
.14 |
.13 |
.19 |
.37 |
.78 |
.87 |
| ATP | 1.01 |
1.09 |
1.00 |
1.02 |
.46 |
.29 |
.78 |
| KLA/ATP | .16 |
.14 |
.15 |
.19 |
.20 |
.26 |
.87 |
|
Prkci | |
NM_008857 |
protein kinase C, iota (Prkci), mRNA [NM_008857] |
KLA | .92 |
.84 |
.75 |
.59 |
.50 |
.66 |
.90 |
| ATP | 1.06 |
1.20 |
1.15 |
1.10 |
1.14 |
1.04 |
1.00 |
| KLA/ATP | .83 |
.92 |
.75 |
.78 |
.99 |
1.06 |
.80 |
|
Prkcq | |
AK085546 |
0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630039J01 product:protein kinase C, theta, full insert sequence [AK085546] |
KLA | .98 |
.99 |
1.01 |
1.00 |
.95 |
.98 |
.97 |
| ATP | 1.06 |
.98 |
1.02 |
1.00 |
.99 |
.99 |
1.04 |
| KLA/ATP | .91 |
1.01 |
.84 |
1.02 |
1.03 |
1.00 |
1.03 |
|
Prkcq | |
NM_008859 |
protein kinase C, theta (Prkcq), mRNA [NM_008859] |
KLA | 1.04 |
1.07 |
1.00 |
1.06 |
1.02 |
.91 |
.87 |
| ATP | 1.06 |
.97 |
.97 |
.99 |
.94 |
1.00 |
.89 |
| KLA/ATP | 1.09 |
1.00 |
1.15 |
1.14 |
.98 |
1.07 |
.96 |
|
Prkcz | |
NM_008860 |
protein kinase C, zeta (Prkcz), transcript variant 1, mRNA [NM_008860] |
KLA | .92 |
.90 |
1.00 |
.99 |
1.07 |
1.05 |
1.12 |
| ATP | 1.01 |
.95 |
.94 |
.93 |
1.04 |
1.04 |
.95 |
| KLA/ATP | .95 |
.94 |
.95 |
.94 |
.99 |
1.02 |
.98 |
|
Pten | |
NM_008960 |
phosphatase and tensin homolog (Pten), mRNA [NM_008960] |
KLA | .79 |
.73 |
.61 |
.59 |
.56 |
.70 |
1.00 |
| ATP | 1.04 |
1.11 |
1.07 |
1.12 |
1.03 |
1.38 |
.83 |
| KLA/ATP | .75 |
.69 |
.60 |
.74 |
.93 |
1.09 |
1.24 |
|
Rab13 | |
AK083292 |
adult male liver tumor cDNA, RIKEN full-length enriched library, clone:C730019P10 product:unclassifiable, full insert sequence. [AK083292] |
KLA | 1.00 |
.99 |
.99 |
.95 |
.96 |
.97 |
.98 |
| ATP | 1.00 |
1.06 |
.95 |
.96 |
1.18 |
1.15 |
.97 |
| KLA/ATP | 1.04 |
1.03 |
1.03 |
1.00 |
1.41 |
1.56 |
1.00 |
|
Rab13 | |
NM_026677 |
RAB13, member RAS oncogene family (Rab13), mRNA [NM_026677] |
KLA | 1.10 |
1.09 |
1.19 |
1.26 |
1.20 |
1.22 |
1.18 |
| ATP | 1.04 |
1.12 |
1.03 |
1.24 |
1.12 |
.81 |
1.14 |
| KLA/ATP | 1.14 |
1.30 |
1.29 |
1.42 |
1.25 |
1.04 |
1.40 |
|
Rab3b | |
NM_023537 |
RAB3B, member RAS oncogene family (Rab3b), mRNA [NM_023537] |
KLA | 1.00 |
.98 |
.99 |
.99 |
.98 |
.97 |
.93 |
| ATP | 1.01 |
.98 |
1.03 |
1.02 |
.97 |
.98 |
.96 |
| KLA/ATP | .99 |
.96 |
1.00 |
1.03 |
.99 |
1.02 |
1.05 |
|
Rhoa | |
NM_016802 |
ras homolog gene family, member A (Rhoa), mRNA [NM_016802] |
KLA | .93 |
1.00 |
1.07 |
.97 |
1.08 |
1.06 |
1.02 |
| ATP | .93 |
.88 |
.49 |
.61 |
.63 |
.78 |
1.05 |
| KLA/ATP | .94 |
.92 |
.59 |
.63 |
.61 |
.78 |
1.12 |
|
Rras | |
NM_009101 |
Harvey rat sarcoma oncogene, subgroup R (Rras), mRNA [NM_009101] |
KLA | .89 |
.89 |
.99 |
.98 |
1.25 |
1.48 |
1.81 |
| ATP | 1.14 |
1.17 |
1.01 |
1.61 |
1.37 |
1.33 |
1.40 |
| KLA/ATP | 1.09 |
1.05 |
1.01 |
1.34 |
1.24 |
1.10 |
1.27 |
|
Rras2 | |
NM_025846 |
related RAS viral (r-ras) oncogene homolog 2 (Rras2), mRNA [NM_025846] |
KLA | 7.72 |
7.35 |
7.03 |
5.47 |
3.21 |
1.03 |
.65 |
| ATP | .92 |
.86 |
.99 |
.95 |
1.86 |
2.13 |
.72 |
| KLA/ATP | 6.51 |
6.50 |
5.94 |
4.45 |
3.05 |
1.72 |
.75 |
|
Spnb2 | |
NM_009260 |
spectrin beta 2 (Spnb2), transcript variant 2, mRNA [NM_009260] |
KLA | 1.29 |
1.20 |
1.33 |
1.18 |
1.06 |
.98 |
.94 |
| ATP | 1.08 |
1.09 |
1.19 |
.78 |
.78 |
.93 |
1.02 |
| KLA/ATP | 1.36 |
1.29 |
1.78 |
.97 |
1.02 |
1.00 |
1.05 |
|
Spnb2 | |
NM_175836 |
spectrin beta 2 (Spnb2), transcript variant 1, mRNA [NM_175836] |
KLA | 1.15 |
1.10 |
1.31 |
1.24 |
1.11 |
.89 |
.80 |
| ATP | 1.01 |
1.01 |
1.08 |
.86 |
.71 |
.54 |
.68 |
| KLA/ATP | 1.13 |
1.21 |
1.40 |
1.04 |
.87 |
.82 |
.92 |
|
Src | |
NM_009271 |
Rous sarcoma oncogene (Src), transcript variant 1, mRNA [NM_009271] |
KLA | 6.99 |
7.23 |
7.54 |
5.99 |
5.34 |
3.39 |
3.00 |
| ATP | 1.02 |
1.06 |
1.06 |
2.08 |
4.41 |
5.03 |
3.97 |
| KLA/ATP | 7.44 |
7.51 |
5.48 |
6.24 |
4.86 |
5.86 |
7.90 |
|
Tjap1 | |
NM_028751 |
tight junction associated protein 1 (Tjap1), mRNA [NM_028751] |
KLA | 1.19 |
1.13 |
1.14 |
1.10 |
1.25 |
1.21 |
1.16 |
| ATP | 1.03 |
1.05 |
.99 |
1.07 |
1.35 |
1.38 |
1.08 |
| KLA/ATP | 1.21 |
1.19 |
.95 |
1.03 |
1.24 |
1.44 |
1.61 |
|
Tjp1 | |
NM_009386 |
tight junction protein 1 (Tjp1), mRNA [NM_009386] |
KLA | 1.00 |
1.03 |
1.07 |
1.00 |
1.03 |
1.03 |
1.09 |
| ATP | 1.01 |
.98 |
1.06 |
1.00 |
1.00 |
1.05 |
1.04 |
| KLA/ATP | .99 |
1.04 |
1.06 |
1.08 |
1.10 |
1.21 |
1.11 |
|
Tjp2 | |
NM_011597 |
tight junction protein 2 (Tjp2), mRNA [NM_011597] |
KLA | .94 |
.89 |
.74 |
.67 |
.59 |
.59 |
.72 |
| ATP | 1.03 |
1.12 |
1.08 |
1.31 |
1.14 |
1.22 |
1.28 |
| KLA/ATP | .97 |
.97 |
.82 |
.84 |
.70 |
.71 |
1.10 |
|
Tjp3 | |
NM_013769 |
tight junction protein 3 (Tjp3), mRNA [NM_013769] |
KLA | .54 |
.55 |
.59 |
.71 |
.71 |
.70 |
.72 |
| ATP | 1.04 |
1.12 |
1.04 |
1.10 |
.64 |
.51 |
.75 |
| KLA/ATP | .60 |
.62 |
.63 |
.65 |
.58 |
.56 |
.60 |
|
Vapa | |
NM_013933 |
vesicle-associated membrane protein, associated protein A (Vapa), mRNA [NM_013933] |
KLA | 1.02 |
1.03 |
1.17 |
1.26 |
1.46 |
1.42 |
1.34 |
| ATP | 1.03 |
1.09 |
1.17 |
1.27 |
1.84 |
2.74 |
1.36 |
| KLA/ATP | 1.04 |
1.04 |
1.06 |
1.34 |
1.69 |
2.15 |
1.50 |
|
Yes1 | |
NM_009535 |
Yamaguchi sarcoma viral (v-yes) oncogene homolog 1 (Yes1), mRNA [NM_009535] |
KLA | .99 |
1.14 |
.97 |
.99 |
.99 |
1.02 |
1.05 |
| ATP | 1.07 |
.98 |
1.00 |
1.09 |
.98 |
.99 |
1.00 |
| KLA/ATP | 1.04 |
1.04 |
.89 |
1.01 |
1.04 |
1.02 |
1.07 |
|